Skip to main content
Fig. 3 | BMC Musculoskeletal Disorders

Fig. 3

From: Adapting MRI as a clinical outcome measure for a facioscapulohumeral muscular dystrophy trial of prednisone and tacrolimus: case report

Fig. 3

STIR and T1 MRI of lower extremity over the treatment period (6 and 12 weeks). The fat and water images derived from the T1 DIXON scan are shown at top and middle throughout the leg volumes across the study interval. In the bottom panel, regions with STIR+ signal are shown with arrows. The STIR+ signal persists at the two treatment time-points

Back to article page